LI
LIMNW
Liminatus Pharma, Inc.
$0.0600
0.00%
$5.5M
No data for this timeframe.
Vol
Market Cap$5.5M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$20.7K
Inst. Activity0 buys / 2 sells
SEC Reports2
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001971387·Prev Close $0.0600
Recent Activity
Jun 3, 2026
SEC
Liminatus Pharma entered into a warrant inducement agreement whereby an accredited investor exercised approximately 10.3
8-K — Impact 5/10
May 20, 2026
SEC
Liminatus Pharma entered a merger agreement to acquire InnocsAI LLC, a private CAR-T therapy company, for 1.6 billion sh
8-K — Impact 6/10
Inst.
WOLVERINE ASSET MANAGEMENT LLC — TRIM
39,373 shares ($1.6K)
Inst.
Clear Street Group Inc. — NEAR_EXIT
100 shares ($4.00)
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| LINDEN ADVISORS LP | $13.1K | — |
| D. E. Shaw & | $3.3K | — |
| WOLVERINE ASSET MANAGEMENT LLC | $1.6K | TRIM |
| TORONTO DOMINION BANK | $1.4K | — |
| LMR Partners LLP | $1.2K | — |
6 institutional holders with $20.7K total value (456,086 shares) as of 2026-Q1. Top holders: LINDEN, D., WOLVERINE. Net selling activity: 2 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | LINDEN ADVISORS LP | 268,199 | $13.1K | 63.6% | — |
| 2 | D. E. Shaw & Co., Inc. | 83,353 | $3.3K | 16.1% | — |
| 3 | WOLVERINE ASSET MANAGEMENT LLC | 39,373 | $1.6K | 7.6% | TRIM -37.3% |
| 4 | TORONTO DOMINION BANK | 35,100 | $1.4K | 6.8% | — |
| 5 | LMR Partners LLP | 29,961 | $1.2K | 5.8% | — |
| 6 | Clear Street Group Inc. | 100 | $4.00 | 0.0% | NEAR_EXIT -100.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 62,795 | 39,373 | -37.3% | $1.6K | 2026-Q1 |
| Clear Street Group Inc. | NEAR_EXIT | 805,177 | 100 | -100.0% | $4.00 | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 200 | 100 | -50.0% | $4.00 | 2025-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 102,987 | 62,863 | -39.0% | $9.3K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 2,020 | 290 | -85.6% | $43.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 300 | 200 | -33.3% | $29.00 | 2025-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 0 neutral. Avg impact: 5.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.